IFNA2 and colorectal carcinoma: Hence, we envisage that the strength of ARI combination relies on re-establishing a normal “epigenetic landscape” by the simultaneous use of azacitidine and romidepsin, which leads to unlock specific genes allowing IFN-α-induced transcriptional activity, with the final result to control most of the cellular signals deregulated during CRC development and progression.